Director exercises options for 30,000 shares and sells 14,514 at CRISPR Therapeutics (CRSP)
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Simeon George, a director at CRISPR Therapeutics (CRSP), exercised options for 30,000 common shares at Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context